Treating sexual desire disorders with flibanserin
US10675280B2 · kind B2 · utility
0Cited by
59References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2019 |
| Grant date | Jun 9, 2020 |
| Priority date | — |
| Expiry date | May 14, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/496
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.